The stein-leventhal syndrome: a curable form of sterility. N Engl J Med 1958;259:420-423.
Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 1992. p. 377-384.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25.
Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 2005;83(5):1343-1346.
Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006 Nov; 91(11):4237-4245.
Evidence-based methodology workshop on polycystic ovary syndrome 3–5 Dec, 2012. Executive summary at http://prevention.nih.gov/workshops/2012/pcos/resources.aspx.
The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin Endocrinol (Oxf) 2007;67(6):811-815.
Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18(5):813-823.
ESE PCOS special interest group. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014 Oct;171(4):P1-29.
Polycystic ovarian syndrome: diagnosis and management. Clinical Medicine and Research 2004;2(1):13-27.
Recommendations for investigation of hyperandrogenism. Ann Endocrinol (Paris) 2010 Feb;71(1):2-7.
Menstrual disturbances in various thyroid diseases. Endocr J 2010;57(12):1017-1022.
Correlation of prolactin and thyroid hormone concentration with menstrual patterns in infertile women. J Reprod Infertil 2009 Oct;10(3):207-212.
LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea. Reprod Biomed Online 2008 Jun;16(6):765-771.
Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 1997;82(11):3728-3733.
The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome. Clin Biochem Rev 2007;28(3):79-92.
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;297(6655):1024-1026.
Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990;336(8724): 1141-1144.
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod 1997;12(11):2359-2365.
Anti-mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012 Aug;27(8):2494-2502.
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011 Nov;26(11):3123-3129.
The prevalence of polycystic ovary syndrome in a normal population according to the rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod 2014 Apr;29(4):791-801.
The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014;20(3):370-385.
Optimal evaluation of the infertile female. Fertil Steril 2006;86(Suppl 5):S264-S267.
Reliability of ovulation tests in infertile women. Obstet Gynecol 2001 Jan;97(1):92-96.
Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. Gynecol Endocrinol 2010 Mar;26(3):152-160.
Do threshold values of ovarian volume and follicle number for diagnosing polycystic ovarian syndrome in Turkish women differ from western countries? Eur J Obstet Gynecol Reprod Biol 2011 Feb;154(2):177-181.
Ovarian volume and follicle number in the diagnosis of polycystic ovary syndrome in Chinese women. Ultrasound Obstet Gynecol 2008 Oct;32(5):700-703.
Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 2013;28(5):1361-1368.
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group* March 2-3, 2007, Thessaloniki, Greece. Hum Reprod 2008;23(3):462-477.
Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 1994 Apr;61(4):598-604.
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011 Feb 16;(2):CD007506.
Treatment of obesity in polycystic ovary syndrome: a position statement of the androgen excess and polycystic ovary syndrome society. Fertil Steril 2009 Dec;92(6):1966-1982.
Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update 2011 Mar-Apr;17(2):171-183.
Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007 Oct;107(10):1755-1767. Review.
Optimal management of subfertility in polycystic ovary syndrome. Int J Womens Health 2014 Jun 13;6:613-621.
An RCT of metformin versus orlistat for the management of obese anovulatory women. Hum Reprod 2009 Apr;24(4):966-967.
Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates. J Hum Reprod Sci 2014 Oct-Dec;7(4):255-261.
Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis 2012;8(4):445-449.
The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005 Dec;90(12):6364-6369.
Clomiphene citrate-end of an era? A minireview. Hum Reprod 2005;20(8):2043-2051.
High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 2003 Nov;18(11):2357-2362.
Induction of ovulation with clomiphene citrate. in: the global library of women's medicine dedicated to the enhancement of women's healthcare. Lib Women's med 2008, DOI: 10.3843/GLOWM. 10237.
Enclomiphene citrate veresus clomiphene citrate for ovulation induction in women with unexplained infertility. Fertility and Sterility, 2013 Sep;100(3):S143.
Comparison of the effect of tamoxifen on endometrial thickness in women with thin endometrium (< 7 mm) undergoing ovulation induction with clomiphene citrate. Fertil Steril 2010;93(6):2091-2093.
Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study. Fertil Steril 2011;95(5):1725-1729.
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014 Jul 10;371(2):119-129.
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. Cooperative Multicenter Reproductive Medicine Network. N Engl J Med 2007 Feb 8;356(6):551-566.
Metformin use in women with polycystic ovary syndrome. Ann Transl Med 2014 Jun;2(6):56.
PCOSMIC: a multi-centre randomized trial in women with polycystic ovary syndrome evaluating metformin for infertility with clomiphene. Hum Reprod 2010 Jul;25(7):1675-1683.
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2014 Nov 18;11:CD006105.
Antioxidants for female subfertility. Cochrane Database Syst Rev 2013 Aug 5; 8:CD007807.
Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes. Hum Reprod 2003;18(2):408-416.
Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 2006;29(2):300-305.
Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 2003;7(6):151-159.
Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol 2012 Jul; 28(7):509-515.
Oral melatonin supplementation improves oocyte and embryo quality in women undergoing in vitro fertilization-embryo transfer. Gynecol Endocrinol 2014;30(5):359-362.
A pilot double-blind randomised placebo-controlled doseresponse trial assessing the effects of melatonin on infertility treatment (MIART): study protocol. BMJ Open 2014;4(8):e005986.
N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrateresistant patients with polycystic ovary syndrome. Fertil Steril 2005 Feb;83(2):367-370.
N-acetyl cysteine in clomiphene citrate resistant polycystic ovary syndrome: a review of reported outcomes. J Pharmacol Pharmacother 2013 Jul-Sep;4(3):187-191.
Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol 2012;77(3):343-350.
Comparative evaluation of pregnancy outcome in gonadotrophin-clomiphene combination vs clomiphene alone in polycystic ovarian syndrome and unexplained infertility: a prospective clinical trial. J Hum Reprod Sci 2010 May;3(2):80-84.
Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis. Gynecol Endocrinol 2013 Mar;29(3):187-191.